---
figid: PMC3149150__fnana-05-00047-g003
figtitle: Striatal-enriched protein tyrosine phosphatase and Alzheimer’s disease
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
organisms_ner:
- Mus musculus
- Homo sapiens
- Rattus norvegicus
- Drosophila melanogaster
pmcid: PMC3149150
filename: fnana-05-00047-g003.jpg
figlink: /pmc/articles/PMC3149150/figure/F3/
number: F3
caption: Striatal-enriched protein tyrosine phosphatase and Alzheimer’s disease. Cognitive
  impairments in AD appear before the formation of Aβ plaques, suggesting that soluble
  Aβ may affect synaptic function. Soluble Aβ increases both STEP levels and phosphorylation.
  First, soluble Aβ inhibits STEP degradation by an Aβ-mediated inhibition of the
  ubiquitin proteasome pathway. Second, soluble Aβ directly binds and activates α7
  nAChRs, leading to Ca2+ influx and activation of calcineurin. Calcineurin/PP1 then
  dephosphorylates and activates STEP. Active STEP promotes the dephosphorylation
  of Fyn, GluA2, and GluN2B (and other substrates not depicted). Dephosphorylation
  of Fyn inactivates it whereas dephosphorylation of GluN2B and GluA2 leads to NMDAR
  and AMPAR internalization from synaptosomal surface membranes and disruption of
  synaptic function.
papertitle: The Role of Striatal-Enriched Protein Tyrosine Phosphatase (STEP) in Cognition.
reftext: Christopher James Fitzpatrick, et al. Front Neuroanat. 2011;5:47.
year: '2011'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8853898
figid_alias: PMC3149150__F3
figtype: Figure
redirect_from: /figures/PMC3149150__F3
ndex: 99937140-df17-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3149150__fnana-05-00047-g003.html
  '@type': Dataset
  description: Striatal-enriched protein tyrosine phosphatase and Alzheimer’s disease.
    Cognitive impairments in AD appear before the formation of Aβ plaques, suggesting
    that soluble Aβ may affect synaptic function. Soluble Aβ increases both STEP levels
    and phosphorylation. First, soluble Aβ inhibits STEP degradation by an Aβ-mediated
    inhibition of the ubiquitin proteasome pathway. Second, soluble Aβ directly binds
    and activates α7 nAChRs, leading to Ca2+ influx and activation of calcineurin.
    Calcineurin/PP1 then dephosphorylates and activates STEP. Active STEP promotes
    the dephosphorylation of Fyn, GluA2, and GluN2B (and other substrates not depicted).
    Dephosphorylation of Fyn inactivates it whereas dephosphorylation of GluN2B and
    GluA2 leads to NMDAR and AMPAR internalization from synaptosomal surface membranes
    and disruption of synaptic function.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - App
  - H2-Ab1
  - Grin1
  - Chrna7
  - Itga7
  - Ppp1r1b
  - Ptpn5
  - Fyn
  - Cbx5
  - Hp
  - Gpr162
  - APP
  - SUCLA2
  - GRIN1
  - GRIN2A
  - GRIN2B
  - GRIN2C
  - GRIN2D
  - GRIN3A
  - GRIN3B
  - CHRNA4
  - PPP1R1B
  - PTPN5
  - FYN
  - DEFA1
  - CBX5
  - DEFA1B
  - PSMA1
  - PSMA2
  - PSMA3
  - PSMA4
  - PSMA5
  - PSMA6
  - PSMA7
  - PSMA8
  - PSMB1
  - PSMB10
  - PSMB2
  - PSMB3
  - PSMB4
  - PSMB5
  - PSMB6
  - PSMB7
  - PSMB8
  - PSMB9
  - PSMC1
  - PSMC2
  - PSMC3
  - PSMC4
  - PSMC5
  - PSMC6
  - PSMD1
  - PSMD10
  - PSMD11
  - PSMD12
  - PSMD13
  - PSMD14
  - PSMD2
  - PSMD3
  - PSMD4
  - PSMD5
  - PSMD6
  - PSMD7
  - PSMD8
  - PSMD9
  - PSME1
  - PSME2
  - PSME3
  - PSMF1
  - SEM1
  - USP5
  - GPR162
  - Chrnb1
  - Chrne
  - ab
  - Appl
  - Nmdar2
  - Nmdar1
  - Prosalpha7
  - nAChRalpha3
  - nAChRalpha7
  - nAChRbeta3
  - nAChRalpha6
  - nAChRalpha5
  - nAChRbeta1
  - nAChRalpha4
  - nAChRalpha1
  - nAChRalpha2
  - nAChRbeta2
  - ca
  - step
  - HP1b
  - HP1D3csd
  - Su(var)205
  - HP1e
  - HP1c
  - rhi
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - Pen
  - alphaTub85E
  - Prosalpha2
  - Glutamate
---
